Hospital admissions due to infections in the national population of people with multiple sclerosis on disease-modifying therapies: Real-world data from NHS England

被引：0
|
作者：
Garjani, Afagh [1 ,2 ]
Osborne, Nick [3 ]
Law, Graham [4 ]
Nightingale, Matthew [3 ]
Evangelou, Nikos [1 ,2 ]
机构：
[1] Univ Nottingham, Sch Med, Mental Hlth & Clin Neurosci Acad Unit, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, Neurol Clin, Nottingham, England
[3] NHS Arden & Greater East Midlands Commissioning S, Leicester, Leics, England
[4] Univ Lincoln, Sch Hlth & Social Care, Coll Hlth & Sci, Lincoln, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O091/2549
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [1] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [2] Real-world effectiveness of oral disease-modifying therapies for multiple sclerosis
    Thanh Phuong Pham Nguyen
    Thibault, Dylan
    Willis, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 124 - 125
  • [3] Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis
    Krysko, Kristen M.
    Graves, Jennifer S.
    Rensel, Mary
    Weinstock-Guttman, Bianca
    Rutatangwa, Alice
    Aaen, Gregory
    Belman, Anita
    Benson, Leslie
    Chitnis, Tanuja
    Gorman, Mark
    Goyal, Manu S.
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Moodley, Manikum
    Ness, Jayne
    Rodriguez, Moses
    Rose, John
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Mas, Michael Waltz
    MStat, T. Charles Casper
    Waubant, Emmanuelle
    ANNALS OF NEUROLOGY, 2020, 88 (01) : 42 - 55
  • [4] Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis
    Kim, Su-Hyun
    Park, Min Su
    Kim, Woojun
    Huh, So-Young
    Shin, Hyun-June
    Hyun, Jae-Won
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (01): : 20 - 26
  • [5] Analysis of oral disease-modifying therapies using real-world data from the German NeuroTransData multiple sclerosis registry
    Braune, Stefan
    Heer, Yannic
    Jarecki, Jana
    Zurcher, Mel
    DeBoer, Erik
    Wisskirchen, Christian
    Biswas, Mousumi
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1019 - 1019
  • [6] Real-world use of disease-modifying therapies in older persons with multiple sclerosis: Findings from the Swiss Multiple Sclerosis Registry
    Stanikic, Mina
    Salmen, Anke
    Chan, Andrew
    Kuhle, Jens
    Kesselring, Jurg
    Kamm, Christian
    Roth, Patrick
    Manjaly, Zina-Mary
    Calabrese, Pasquale
    Gobbi, Claudio
    Zecca, Chiara
    Mueller, Stefanie
    Pot, Caroline
    Rapold, Irene
    von Wyl, Viktor
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 377 - 378
  • [7] Effectiveness of COVID-19 vaccines in people with multiple sclerosis receiving disease-modifying therapies: a total population study of national health service (NHS) England
    Evangelou, N.
    Patel, S.
    Law, G. R.
    Bharkhada, D.
    Rashid, W.
    Coles, A.
    Garjani, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 103 - 103
  • [8] Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
    Sportiello, Liberata
    Di Napoli, Raffaella
    Balzano, Nunzia
    Mascolo, Annamaria
    Ruggiero, Rosanna
    Di Costanzo, Luigi
    Monaco, Davida
    Maniscalco, Giorgia Teresa
    Capuano, Annalisa
    PHARMACEUTICALS, 2023, 16 (11)
  • [9] Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
    Fox, Robert J.
    Mehta, Rina
    Pham, Timothy
    Park, Julie
    Wilson, Kathleen
    Bonafede, Machaon
    BMC NEUROLOGY, 2022, 22 (01)
  • [10] Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
    Robert J. Fox
    Rina Mehta
    Timothy Pham
    Julie Park
    Kathleen Wilson
    Machaon Bonafede
    BMC Neurology, 22
12345